Ace Report Cover
WCO-IOF 2016: Greater BMD increase after 1 year of romosozumab vesus teripratide
Reprints
Cite This
Reprints
Cite This
AceReport Image
Metabolic Disorders
WCO-IOF 2016: Greater BMD increase after 1 year of romosozumab vesus teripratide

436 postmenopausal women with osteoporosis who had been administered oral bisphosphonate therapy for 3 years prior were randomized in a phase 3 clinical trial to subcutaneous romosozumab or subcutaneous teriparatide. The purpose of this study was to compare the change in bone mineral density after 1 year of treatment between the two groups. Reported results demonstrated a significantly greater increase in total hip and lumbar spine BMD in the romosozumab group compared to the teriparatide group.

Unlock the full article

Get unlimited access to OrthoEvidence with a free trial
Start Trial

Critical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics

Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics

Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions

Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics

Or continue reading this full article
Register Now
AskOE
Search
Close Search Window
Welcome Back!
Forgot Password?
Create an Account

Account will be affiliated with


OR
Forgot Password?

OR
Check your email

If an account exists with the provided email address, a password reset email will be sent to you. If you don't see the email, please check your spam or junk folder.

For further assistance, contact our support team.

Cite this Ace Report

OrthoEvidence. WCO-IOF 2016: Greater BMD increase after 1 year of romosozumab vesus teripratide. ACE Report. 2016;6(5):15. Available from: https://myorthoevidence.com/AceReport/Report/

Copy Citation
Share this Ace Report